{"transactions":[{"id":903414,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2026-02-18T00:31:10.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":false,"shares":367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2026."}],"balance_after":1101,"derivative":{"underlying":"Common Stock","underlying_shares":367},"source":{"system":"sec-edgar","filing":"0000874716-26-000026","document":"wk-form4_1771374667.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471626000026/wk-form4_1771374667.xml","form_type":"4"}},{"id":903413,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2026-02-18T00:31:10.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":false,"shares":301,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025."}],"balance_after":602,"derivative":{"underlying":"Common Stock","underlying_shares":301},"source":{"system":"sec-edgar","filing":"0000874716-26-000026","document":"wk-form4_1771374667.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471626000026/wk-form4_1771374667.xml","form_type":"4"}},{"id":903412,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2026-02-18T00:31:10.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":false,"shares":188,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024."}],"balance_after":188,"derivative":{"underlying":"Common Stock","underlying_shares":188},"source":{"system":"sec-edgar","filing":"0000874716-26-000026","document":"wk-form4_1771374667.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471626000026/wk-form4_1771374667.xml","form_type":"4"}},{"id":903411,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2026-02-18T00:31:10.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":false,"shares":148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU represents a contingent right to receive one share of Issuer common stock that vested in four annual installments, beginning February 14, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each RSU represents a contingent right to receive one share of Issuer common stock that vested in four annual installments, beginning February 14, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each RSU represents a contingent right to receive one share of Issuer common stock that vested in four annual installments, beginning February 14, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":148},"source":{"system":"sec-edgar","filing":"0000874716-26-000026","document":"wk-form4_1771374667.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471626000026/wk-form4_1771374667.xml","form_type":"4"}},{"id":903410,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2026-02-18T00:31:10.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":1620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vests in three annual installments, beginning February 14, 2027."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vests in three annual installments, beginning February 14, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vests in three annual installments, beginning February 14, 2027."}],"balance_after":1620,"derivative":{"underlying":"Common Stock","underlying_shares":1620},"source":{"system":"sec-edgar","filing":"0000874716-26-000026","document":"wk-form4_1771374667.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471626000026/wk-form4_1771374667.xml","form_type":"4"}},{"id":903409,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2026-02-18T00:31:10.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":1262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2027."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2027."}],"balance_after":1262,"derivative":{"underlying":"Common Stock","underlying_shares":1262},"source":{"system":"sec-edgar","filing":"0000874716-26-000026","document":"wk-form4_1771374667.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471626000026/wk-form4_1771374667.xml","form_type":"4"}},{"id":903408,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Incentive Stock Option (right-to-buy)","published_at":"2026-02-18T00:31:10.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030."}],"balance_after":162,"derivative":{"exercise_price":617.2,"expiration_date":"2036-02-11","underlying":"Common Stock","underlying_shares":162},"source":{"system":"sec-edgar","filing":"0000874716-26-000026","document":"wk-form4_1771374667.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471626000026/wk-form4_1771374667.xml","form_type":"4"}},{"id":903407,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2026-02-18T00:31:10.000Z","date":"2026-02-12","kind":"grant","planned":false,"acquired":true,"shares":5361,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027."}],"balance_after":5361,"derivative":{"exercise_price":617.2,"expiration_date":"2036-02-11","underlying":"Common Stock","underlying_shares":5361},"source":{"system":"sec-edgar","filing":"0000874716-26-000026","document":"wk-form4_1771374667.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471626000026/wk-form4_1771374667.xml","form_type":"4"}},{"id":903406,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2026-02-18T00:31:10.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":302,"price":629.35,"value":190063.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026."}],"balance_after":2156.659,"source":{"system":"sec-edgar","filing":"0000874716-26-000026","document":"wk-form4_1771374667.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471626000026/wk-form4_1771374667.xml","form_type":"4"}},{"id":903405,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2026-02-18T00:31:10.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":true,"shares":367,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2458.659,"source":{"system":"sec-edgar","filing":"0000874716-26-000026","document":"wk-form4_1771374667.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471626000026/wk-form4_1771374667.xml","form_type":"4"}},{"id":903404,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2026-02-18T00:31:10.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":true,"shares":301,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2091.659,"source":{"system":"sec-edgar","filing":"0000874716-26-000026","document":"wk-form4_1771374667.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471626000026/wk-form4_1771374667.xml","form_type":"4"}},{"id":903403,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2026-02-18T00:31:10.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":true,"shares":188,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1790.659,"source":{"system":"sec-edgar","filing":"0000874716-26-000026","document":"wk-form4_1771374667.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471626000026/wk-form4_1771374667.xml","form_type":"4"}},{"id":903402,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2026-02-18T00:31:10.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":true,"shares":148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes a total of 21 shares purchased under the Issuer Employee Stock Purchase Plan on September 30, 2025 and December 31, 2025."}],"balance_after":1602.659,"source":{"system":"sec-edgar","filing":"0000874716-26-000026","document":"wk-form4_1771374667.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471626000026/wk-form4_1771374667.xml","form_type":"4"}},{"id":1050675,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2025-09-03T21:56:31.000Z","date":"2025-09-01","kind":"exercise","planned":false,"acquired":false,"shares":18,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning September 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning September 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning September 1, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":18},"source":{"system":"sec-edgar","filing":"0000874716-25-000150","document":"wk-form4_1756936587.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000150/wk-form4_1756936587.xml","form_type":"4"}},{"id":1050674,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2025-09-03T21:56:31.000Z","date":"2025-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":5,"price":647.09,"value":3235.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Closing price of Issuer common stock on the Nasdaq Global Select Market on August 29, 2025."}],"balance_after":1433.659,"source":{"system":"sec-edgar","filing":"0000874716-25-000150","document":"wk-form4_1756936587.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000150/wk-form4_1756936587.xml","form_type":"4"}},{"id":1050673,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2025-09-03T21:56:31.000Z","date":"2025-09-01","kind":"exercise","planned":false,"acquired":true,"shares":18,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes a total of 28.709 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2025 and June 30, 2025."}],"balance_after":1438.659,"source":{"system":"sec-edgar","filing":"0000874716-25-000150","document":"wk-form4_1756936587.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000150/wk-form4_1756936587.xml","form_type":"4"}},{"id":1265349,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2025-02-19T02:43:57.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":false,"shares":301,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025."}],"balance_after":903,"derivative":{"underlying":"Common Stock","underlying_shares":301},"source":{"system":"sec-edgar","filing":"0000874716-25-000029","document":"wk-form4_1739933031.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000029/wk-form4_1739933031.xml","form_type":"4"}},{"id":1265348,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2025-02-19T02:43:57.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":false,"shares":189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024."}],"balance_after":376,"derivative":{"underlying":"Common Stock","underlying_shares":189},"source":{"system":"sec-edgar","filing":"0000874716-25-000029","document":"wk-form4_1739933031.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000029/wk-form4_1739933031.xml","form_type":"4"}},{"id":1265347,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2025-02-19T02:43:57.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":false,"shares":593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vested in one installment on February 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vested in one installment on February 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vested in one installment on February 14, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":593},"source":{"system":"sec-edgar","filing":"0000874716-25-000029","document":"wk-form4_1739933031.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000029/wk-form4_1739933031.xml","form_type":"4"}},{"id":1265346,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2025-02-19T02:43:57.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":false,"shares":148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2023."}],"balance_after":148,"derivative":{"underlying":"Common Stock","underlying_shares":148},"source":{"system":"sec-edgar","filing":"0000874716-25-000029","document":"wk-form4_1739933031.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000029/wk-form4_1739933031.xml","form_type":"4"}},{"id":1265345,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2025-02-19T02:43:57.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":1468,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This  RSU grant vests in four annual installments, beginning February 14, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This  RSU grant vests in four annual installments, beginning February 14, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This  RSU grant vests in four annual installments, beginning February 14, 2026."}],"balance_after":1468,"derivative":{"underlying":"Common Stock","underlying_shares":1468},"source":{"system":"sec-edgar","filing":"0000874716-25-000029","document":"wk-form4_1739933031.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000029/wk-form4_1739933031.xml","form_type":"4"}},{"id":1265344,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Incentive Stock Option (right-to-buy)","published_at":"2025-02-19T02:43:57.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":217,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2029."}],"balance_after":217,"derivative":{"exercise_price":459.76,"expiration_date":"2035-02-12","underlying":"Common Stock","underlying_shares":217},"source":{"system":"sec-edgar","filing":"0000874716-25-000029","document":"wk-form4_1739933031.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000029/wk-form4_1739933031.xml","form_type":"4"}},{"id":1265343,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2025-02-19T02:43:57.000Z","date":"2025-02-13","kind":"grant","planned":false,"acquired":true,"shares":6320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2026."}],"balance_after":6320,"derivative":{"exercise_price":459.76,"expiration_date":"2035-02-12","underlying":"Common Stock","underlying_shares":6320},"source":{"system":"sec-edgar","filing":"0000874716-25-000029","document":"wk-form4_1739933031.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000029/wk-form4_1739933031.xml","form_type":"4"}},{"id":1265342,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2025-02-19T02:43:57.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":374,"price":444.53,"value":166254.22,"ownership":{"direct":true},"balance_after":1391.95,"source":{"system":"sec-edgar","filing":"0000874716-25-000029","document":"wk-form4_1739933031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000029/wk-form4_1739933031.xml","form_type":"4"}},{"id":1265341,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2025-02-19T02:43:57.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":true,"shares":301,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1765.95,"source":{"system":"sec-edgar","filing":"0000874716-25-000029","document":"wk-form4_1739933031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000029/wk-form4_1739933031.xml","form_type":"4"}},{"id":1265340,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2025-02-19T02:43:57.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":true,"shares":189,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1464.95,"source":{"system":"sec-edgar","filing":"0000874716-25-000029","document":"wk-form4_1739933031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000029/wk-form4_1739933031.xml","form_type":"4"}},{"id":1265339,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2025-02-19T02:43:57.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":true,"shares":593,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1275.95,"source":{"system":"sec-edgar","filing":"0000874716-25-000029","document":"wk-form4_1739933031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000029/wk-form4_1739933031.xml","form_type":"4"}},{"id":1265338,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2025-02-19T02:43:57.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":true,"shares":148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes a total of 25 shares purchased under the Issuer Employee Stock Purchase Plan on September 30, 2024 and December 31, 2024."}],"balance_after":682.95,"source":{"system":"sec-edgar","filing":"0000874716-25-000029","document":"wk-form4_1739933031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471625000029/wk-form4_1739933031.xml","form_type":"4"}},{"id":1416841,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2024-09-05T00:03:05.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":false,"shares":18,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning September 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning September 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning September 1, 2022."}],"balance_after":18,"derivative":{"underlying":"Common Stock","underlying_shares":18},"source":{"system":"sec-edgar","filing":"0000874716-24-000128","document":"wk-form4_1725489035.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000128/wk-form4_1725489035.xml","form_type":"4"}},{"id":1416840,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2024-09-05T00:03:05.000Z","date":"2024-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":5,"price":481.33,"value":2406.65,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Closing price of Issuer common stock on August 30, 2024."}],"balance_after":509.95,"source":{"system":"sec-edgar","filing":"0000874716-24-000128","document":"wk-form4_1725489035.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000128/wk-form4_1725489035.xml","form_type":"4"}},{"id":1416839,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2024-09-05T00:03:05.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":true,"shares":18,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes a total of 22 shares purchased under the Issuer's Employee Stock Purchase Plan on March 29, 2024 and June 28, 2024."}],"balance_after":514.95,"source":{"system":"sec-edgar","filing":"0000874716-24-000128","document":"wk-form4_1725489035.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000128/wk-form4_1725489035.xml","form_type":"4"}},{"id":1639651,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2024-02-16T22:58:31.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":false,"shares":189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024."}],"balance_after":565,"derivative":{"underlying":"Common Stock","underlying_shares":189},"source":{"system":"sec-edgar","filing":"0000874716-24-000043","document":"wk-form4_1708124290.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000043/wk-form4_1708124290.xml","form_type":"4"}},{"id":1639650,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2024-02-16T22:58:31.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":false,"shares":148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023."}],"balance_after":296,"derivative":{"underlying":"Common Stock","underlying_shares":148},"source":{"system":"sec-edgar","filing":"0000874716-24-000043","document":"wk-form4_1708124290.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000043/wk-form4_1708124290.xml","form_type":"4"}},{"id":1639649,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2024-02-16T22:58:31.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":1204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2025."}],"balance_after":1204,"derivative":{"underlying":"Common Stock","underlying_shares":1204},"source":{"system":"sec-edgar","filing":"0000874716-24-000043","document":"wk-form4_1708124290.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000043/wk-form4_1708124290.xml","form_type":"4"}},{"id":1639648,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Incentive Stock Option (right-to-buy)","published_at":"2024-02-16T22:58:31.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":178,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2028."}],"balance_after":178,"derivative":{"exercise_price":560.56,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":178},"source":{"system":"sec-edgar","filing":"0000874716-24-000043","document":"wk-form4_1708124290.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000043/wk-form4_1708124290.xml","form_type":"4"}},{"id":1639647,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2024-02-16T22:58:31.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":5407,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2025."}],"balance_after":5407,"derivative":{"exercise_price":560.56,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":5407},"source":{"system":"sec-edgar","filing":"0000874716-24-000043","document":"wk-form4_1708124290.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000043/wk-form4_1708124290.xml","form_type":"4"}},{"id":1639646,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2024-02-16T22:58:31.000Z","date":"2024-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":108,"price":560.56,"value":60540.48,"ownership":{"direct":true},"balance_after":474.95,"source":{"system":"sec-edgar","filing":"0000874716-24-000043","document":"wk-form4_1708124290.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000043/wk-form4_1708124290.xml","form_type":"4"}},{"id":1639645,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2024-02-16T22:58:31.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":true,"shares":189,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":582.95,"source":{"system":"sec-edgar","filing":"0000874716-24-000043","document":"wk-form4_1708124290.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000043/wk-form4_1708124290.xml","form_type":"4"}},{"id":1639644,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2024-02-16T22:58:31.000Z","date":"2024-02-14","kind":"exercise","planned":false,"acquired":true,"shares":148,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes a total of 25.247 shares purchased under the Issuer Employee Stock Purchase Plan on September 29, 2023 and December 29, 2023."}],"balance_after":393.95,"source":{"system":"sec-edgar","filing":"0000874716-24-000043","document":"wk-form4_1708124290.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471624000043/wk-form4_1708124290.xml","form_type":"4"}},{"id":1788075,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2023-09-06T21:01:13.000Z","date":"2023-09-01","kind":"exercise","planned":false,"acquired":false,"shares":19,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning September 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning September 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning September 1, 2022."}],"balance_after":1827,"derivative":{"underlying":"Common Stock","underlying_shares":19},"source":{"system":"sec-edgar","filing":"0000874716-23-000121","document":"wk-form4_1694034061.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000121/wk-form4_1694034061.xml","form_type":"4"}},{"id":1788074,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-09-06T21:01:13.000Z","date":"2023-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":5,"price":511.29,"value":2556.45,"ownership":{"direct":true},"balance_after":220.703,"source":{"system":"sec-edgar","filing":"0000874716-23-000121","document":"wk-form4_1694034061.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000121/wk-form4_1694034061.xml","form_type":"4"}},{"id":1788073,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-09-06T21:01:13.000Z","date":"2023-09-01","kind":"exercise","planned":false,"acquired":true,"shares":19,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes a total of 26.7030 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2023 and June 30, 2023."}],"balance_after":225.703,"source":{"system":"sec-edgar","filing":"0000874716-23-000121","document":"wk-form4_1694034061.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000087471623000121/wk-form4_1694034061.xml","form_type":"4"}},{"id":2012226,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2023-02-16T23:55:06.000Z","date":"2023-02-14","kind":"exercise","acquired":false,"shares":149,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023."}],"balance_after":1846,"derivative":{"underlying":"Common Stock","underlying_shares":149},"source":{"system":"sec-edgar","filing":"0001567619-23-003222","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923003222/doc1.xml","form_type":"4"}},{"id":2012225,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-02-16T23:55:06.000Z","date":"2023-02-14","kind":"tax_withholding","acquired":true,"shares":47,"price":503.65,"value":23671.55,"ownership":{"direct":true},"balance_after":180,"source":{"system":"sec-edgar","filing":"0001567619-23-003222","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923003222/doc1.xml","form_type":"4"}},{"id":2012224,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2023-02-16T23:55:06.000Z","date":"2023-02-14","kind":"exercise","acquired":true,"shares":149,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":227,"source":{"system":"sec-edgar","filing":"0001567619-23-003222","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923003222/doc1.xml","form_type":"4"}},{"id":2023697,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2023-02-10T22:04:15.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":754,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024."}],"balance_after":1995,"derivative":{"underlying":"Common Stock","underlying_shares":754},"source":{"system":"sec-edgar","filing":"0001567619-23-002396","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923002396/doc1.xml","form_type":"4"}},{"id":2023696,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Incentive Stock Option (right-to-buy)","published_at":"2023-02-10T22:04:15.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":201,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2027."}],"balance_after":201,"derivative":{"exercise_price":497.43,"expiration_date":"2033-02-07","underlying":"Common Stock","underlying_shares":201},"source":{"system":"sec-edgar","filing":"0001567619-23-002396","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923002396/doc1.xml","form_type":"4"}},{"id":2023695,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2023-02-10T22:04:15.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":5316,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2024."}],"balance_after":5316,"derivative":{"exercise_price":497.43,"expiration_date":"2033-02-07","underlying":"Common Stock","underlying_shares":5316},"source":{"system":"sec-edgar","filing":"0001567619-23-002396","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761923002396/doc1.xml","form_type":"4"}},{"id":2166558,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2022-09-06T21:00:14.000Z","date":"2022-09-01","kind":"exercise","acquired":false,"shares":19,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning September 1, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning September 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning September 1, 2022."}],"balance_after":1241,"derivative":{"underlying":"Common Stock","underlying_shares":19},"source":{"system":"sec-edgar","filing":"0001567619-22-017058","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922017058/doc1.xml","form_type":"4"}},{"id":2166557,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2022-09-06T21:00:14.000Z","date":"2022-09-01","kind":"tax_withholding","acquired":false,"shares":6,"price":349.93,"value":2099.58,"ownership":{"direct":true},"balance_after":43,"source":{"system":"sec-edgar","filing":"0001567619-22-017058","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922017058/doc1.xml","form_type":"4"}},{"id":2166556,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Common Stock","published_at":"2022-09-06T21:00:14.000Z","date":"2022-09-01","kind":"exercise","acquired":true,"shares":19,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes a total of 20 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2022 and June 30, 2022."}],"balance_after":49,"source":{"system":"sec-edgar","filing":"0001567619-22-017058","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922017058/doc1.xml","form_type":"4"}},{"id":2392982,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2022-02-17T00:27:09.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":593,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of Issuer common stock.  This RSU grant vests in one installment on February 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each RSU represents a contingent right to receive one share of Issuer common stock.  This RSU grant vests in one installment on February 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each RSU represents a contingent right to receive one share of Issuer common stock.  This RSU grant vests in one installment on February 14, 2025."}],"balance_after":1260,"derivative":{"underlying":"Common Stock","underlying_shares":593},"source":{"system":"sec-edgar","filing":"0001567619-22-004786","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922004786/doc1.xml","form_type":"4"}},{"id":2392981,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2022-02-17T00:27:09.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":593,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023."}],"balance_after":667,"derivative":{"underlying":"Common Stock","underlying_shares":593},"source":{"system":"sec-edgar","filing":"0001567619-22-004786","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922004786/doc1.xml","form_type":"4"}},{"id":2392980,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Incentive Stock Option (right-to-buy)","published_at":"2022-02-17T00:27:09.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":197,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant."}],"balance_after":197,"derivative":{"exercise_price":505.53,"expiration_date":"2032-02-13","underlying":"Common Stock","underlying_shares":197},"source":{"system":"sec-edgar","filing":"0001567619-22-004786","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922004786/doc1.xml","form_type":"4"}},{"id":2392979,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2022-02-17T00:27:09.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":5043,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2023."}],"balance_after":5043,"derivative":{"exercise_price":505.53,"expiration_date":"2032-02-13","underlying":"Common Stock","underlying_shares":5043},"source":{"system":"sec-edgar","filing":"0001567619-22-004786","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761922004786/doc1.xml","form_type":"4"}},{"id":2580369,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Restricted Stock Unit","published_at":"2021-09-03T21:01:14.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":74,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning September 1, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning September 1, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning September 1, 2021."}],"balance_after":74,"derivative":{"underlying":"Common Stock","underlying_shares":74},"source":{"system":"sec-edgar","filing":"0001567619-21-016750","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921016750/doc1.xml","form_type":"4"}},{"id":2580368,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Incentive Stock Option (right-to-buy)","published_at":"2021-09-03T21:01:14.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":588,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning September 1, 2022."}],"balance_after":588,"derivative":{"exercise_price":690.7,"expiration_date":"2031-08-31","underlying":"Common Stock","underlying_shares":588},"source":{"system":"sec-edgar","filing":"0001567619-21-016750","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921016750/doc1.xml","form_type":"4"}},{"id":2580367,"issuer":{"id":3057,"kind":"organization","name":"IDEXX LABORATORIES INC /DE","symbol":"IDXX"},"owners":[{"id":66333,"kind":"person","name":"Smith Martin Alexander","position":1,"cik":"0001621358","reported_name":"Smith Martin Alexander","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice President"}}],"security":"Non-Qualified Stock Option (right-to-buy)","published_at":"2021-09-03T21:01:14.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":124,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning September 1, 2022."}],"balance_after":124,"derivative":{"exercise_price":690.7,"expiration_date":"2031-08-31","underlying":"Common Stock","underlying_shares":124},"source":{"system":"sec-edgar","filing":"0001567619-21-016750","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/874716/000156761921016750/doc1.xml","form_type":"4"}}]}